InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,708.75
(
-0.93%
)
US TECH 100
19,231.20
(
-0.10%
)
Dow Jones
42,156.97
(
-0.41%
)
Brent Oil
75.75
(
1.78%
)
Bitcoin
61,143.20
(
0.51%
)
Post# of 11554
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

StocksDiva

Send PM Follow Ignore
Followers 378
Posts 20728
Boards Moderated 2
Alias Born 03/28/2010

StocksDiva

Re: StocksDiva post# 11100

Thursday, 01/17/2013 8:21:30 AM

Thursday, January 17, 2013 8:21:30 AM

Post# of 11554
Astex Pharmaceuticals (ASTX) announced that collaborators Cancer Research UK and its commercial arm Cancer Research Technology are launching a trial of an experimental drug shown to simultaneously block many enzymes that control cancer cell growth and death. The 'master-switch' experimental drug, owned by Astex Pharmaceuticals, is being studied in a range of cancer types.

StocksDiva Bio Bin Board...Come say hi!!!



ALWAYS DO YOUR OWN DUE DILIGENCE!!! ALWAYS

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up